Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Positive modulation of cerebellar α6GABA A receptors for treating essential tremor: a proof-of-concept study in harmaline-treated mice

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.04.19.440397Source: DataRank Database

Positive modulation of cerebellar α6GABA A receptors for treating essential tremor: a proof-of-concept study in harmaline-treated mice is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (18)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Ming Tatt Lee ORCID,Werner Sieghart ORCID,Daniel E. Knutson ORCID,Laurin Wimmer ORCID,Dishary Sharmin ORCID

Live enrichment

PubMed:19162232 OpenAlex:https://openalex.org/W3154740427

Austrian Science Fund (FWF)

Grant: W 1232

Molecular Drug Targets

National Institutes of Health

Grant: 1R01AA029023-01

GABA-A receptor subtype mechanisms and the abuse-related effects of alcohol

National Institutes of Health

Grant: 5R01MH096463-05

Design of New Therapeutic Agents to Treat Schizophrenia

greenLicense: https://www.biorxiv.org/about/FAQ#license

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2021/04/20/2021.04.19.440397.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.04.19.440397

repositoryhttps://doi.org/10.1101/2021.04.19.440397

https://dx.doi.org/10.1101/2021.04.19.440397

Fields of Study

Neuroscience and Neuropharmacology ResearchNeurological disorders and treatmentsNeuroscience and Neural Engineering0301 basic medicine03 medical and health sciences0302 clinical medicine

Keywords

HarmalinePharmacologyCerebellumAntagonistEssential tremorChemistryMedicineReceptorInternal medicineEndocrinologyNeurosciencePsychology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being